Ac immune to present at the 2022 jefferies healthcare conference

Lausanne, switzerland, may 31, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings during the 2022 jefferies healthcare conference, which is taking place at the marriott marquis hotel in new york, ny from june 8-10, 2022.
ACIU Ratings Summary
ACIU Quant Ranking